Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: Curt Whitaker who wrote (17747)	1/14/1999 8:50:00 AM
From: AlienTech	Respond to of 23519

>>? With our lawsuit-happy society? << Did you see the recent ads? ATTENTION: Families of cancer patients that died in 89-93 If the person died as a result off participation in clinical tests of the drug hydrazine sulfate between 1989 and 1993 you may be eligiable to be part of a class action lawsuit against the national cancer institue. The national cancer institute FAILED to inform patients that the concomitant use of certain medications, tranquilizers, barbiturates or alcohol during the test could deactivate the therapeutic action of hydrazine sulfate and induce mobidity and mortaloty in patients. Please write to The Kathy Keeton foundation 277 park avenue, fouth floor New Your, NY 10172-0003 email hydrazine@generalmedia.com